Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...
Anti-TNF therapies are the first-choice biologic class in the treatment of RA, but are expensive therapies compared with traditional DMARDs. The majority of rheumatologists currently cycle/switch ...
Biologics for rheumatoid arthritis (RA) are generally quick-acting and effective, but their effectiveness and the time it takes to see results can vary. Many are FDA approved, including adalimumab ...
A safe and effective oral drug would threaten several multibillion-dollar biologic franchises, not only in rheumatoid arthritis but also in several other autoimmune conditions, including Crohn's ...
Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune joint pain, with women said to be two to three times more at risk than men.